Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Prostate cancer metastatic

Not recruiting

Registered drug

Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Metformin to Prevent High Blood Sugar in Advanced Breast Cancer Patients with Alpelisib and Endocrine Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study on Trastuzumab Deruxtecan, Trastuzumab, and Pertuzumab for Patients with HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Ipilimumab with Chemotherapy for Patients with Stage IV Non-Small Cell Lung Cancer and Brain Metastases

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Systemic lupus erythematosus+3

Not recruiting

Investigational

Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Enpatoran

Contact Research Centre

Pancreatic carcinoma metastatic

Not recruiting

Registered drugNo placebo

Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Non-small cell lung cancer stage III

Not recruiting

Registered drugNo placebo

Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Find therapies in clinical trials near you – page 7

99 trials match your criteria

Prostate cancer metastatic

Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Non-small cell lung cancer+1

Study Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Hormone receptor positive HER2 negative breast cancer

Study on Metformin to Prevent High Blood Sugar in Advanced Breast Cancer Patients with Alpelisib and Endocrine Therapy

Non-small cell lung cancer

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

HER2 positive breast cancer

Study on Trastuzumab Deruxtecan, Trastuzumab, and Pertuzumab for Patients with HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer

Non-small cell lung cancer+2

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Non-small cell lung cancer

Study of Nivolumab and Ipilimumab with Chemotherapy for Patients with Stage IV Non-Small Cell Lung Cancer and Brain Metastases

Systemic lupus erythematosus+3

Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

Pancreatic carcinoma metastatic

Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

Non-small cell lung cancer stage III

Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.